Cold Spring Harbor Laboratory: Are Pro-Oxidants Anti-Prostate Cancer?
January 08, 2025
January 08, 2025
COLD SPRING HARBOR, New York, Jan. 8 (TNSres) -- The Cold Spring Harbor Laboratory issued the following news:
Prostate cancer is the second-most common cancer among men in the U.S. after skin cancer. It's also the second deadliest after lung cancer. So, even though most people who get the disease don't die from it, prostate cancer remains a leading issue in men's health. A clinical study in the early 2000s sought to determine whether supplements called antioxidants co . . .
Prostate cancer is the second-most common cancer among men in the U.S. after skin cancer. It's also the second deadliest after lung cancer. So, even though most people who get the disease don't die from it, prostate cancer remains a leading issue in men's health. A clinical study in the early 2000s sought to determine whether supplements called antioxidants co . . .
